Pages that link to "Q53411999"
Jump to navigation
Jump to search
The following pages link to p53 alterations predict tumor response to neoadjuvant chemotherapy in head and neck squamous cell carcinoma: a prospective series. (Q53411999):
Displaying 50 items.
- Patient-derived tumour xenografts as models for oncology drug development (Q24604068) (← links)
- Lessons learned from next-generation sequencing in head and neck cancer (Q27009209) (← links)
- Novel gain of function activity of p53 mutants: activation of the dUTPase gene expression leading to resistance to 5-fluorouracil (Q28208559) (← links)
- Gene expression classification of colon cancer into molecular subtypes: characterization, validation, and prognostic value (Q28488319) (← links)
- Cisplatin: mode of cytotoxic action and molecular basis of resistance (Q29615385) (← links)
- Clinical update on cancer: molecular oncology of head and neck cancer (Q33695197) (← links)
- Allelic imbalance at p53 and microsatellite instability are predictive markers for resistance to chemotherapy in gastric carcinoma (Q33832043) (← links)
- Evaluating the arrayed primer extension resequencing assay of TP53 tumor suppressor gene (Q34025309) (← links)
- The role of p53, PCNA and Ki-67 as outcome predictors in the treatment of laryngeal cancer (Q34480875) (← links)
- Cancer of the oropharynx (Q34498121) (← links)
- p53 in head and neck cancer: Functional consequences and environmental implications of TP53mutations (Q34498550) (← links)
- DNA-bound platinum is the major determinant of cisplatin sensitivity in head and neck squamous carcinoma cells (Q34684546) (← links)
- End points for new agents in induction chemotherapy for locally advanced head and neck cancers. (Q34784828) (← links)
- Differentiation of irradiation and cetuximab induced skin reactions in patients with locally advanced head and neck cancer undergoing radioimmunotherapy: the HICARE protocol (head and neck cancer: immunochemo and radiotherapy with erbitux) - a multi (Q34820775) (← links)
- Clinical relevance of molecular markers in lung cancer. (Q35008670) (← links)
- The p53 network in head and neck cancer (Q35078417) (← links)
- TP53 and head and neck neoplasms (Q35078742) (← links)
- Sequencing the head and neck cancer genome: implications for therapy (Q35087559) (← links)
- Novel biomarker panel predicts prognosis in human papillomavirus-negative oropharyngeal cancer: an analysis of the TAX 324 trial (Q35174609) (← links)
- Molecular markers in clinical radiation oncology (Q35208840) (← links)
- The MDM2 promoter polymorphism SNP309T-->G and the risk of uterine leiomyosarcoma, colorectal cancer, and squamous cell carcinoma of the head and neck (Q35448964) (← links)
- Disruptive TP53 Mutation Is Associated with Aggressive Disease Characteristics in an Orthotopic Murine Model of Oral Tongue Cancer (Q35510945) (← links)
- Immunohistochemical Determination of p53 Protein Overexpression for Predicting p53 Gene Mutations in Hepatocellular Carcinoma: A Meta-Analysis (Q36079974) (← links)
- Human Papillomavirus 16 Infection and TP53 Mutation: Two Distinct Pathogeneses for Oropharyngeal Squamous Cell Carcinoma in an Eastern Chinese Population (Q36165303) (← links)
- Association between the cytogenetic profile of tumor cells and response to preoperative radiochemotherapy in locally advanced rectal cancer. (Q36193815) (← links)
- Genetic factors influencing pyrimidine-antagonist chemotherapy. (Q36205831) (← links)
- Molecular markers of head and neck squamous cell carcinoma: promising signs in need of prospective evaluation (Q36311981) (← links)
- Reassessment of the role of induction chemotherapy for head and neck cancer (Q36524702) (← links)
- Application of a patient-derived xenograft model in cytolytic viral activation therapy for nasopharyngeal carcinoma (Q36544568) (← links)
- Tumour stage, node stage, p53 gene status, and bcl-2 protein expression as predictors of tumour response to platin-fluorouracil chemotherapy in patients with squamous-cell carcinoma of the head and neck (Q36646450) (← links)
- Mutant p53 proteins: between loss and gain of function (Q36661775) (← links)
- Molecular pathogenesis of oral squamous cell carcinoma: implications for therapy (Q37039386) (← links)
- A naturally occurring feline model of head and neck squamous cell carcinoma (Q37061281) (← links)
- Molecular techniques and genetic alterations in head and neck cancer (Q37233399) (← links)
- Cardiac dysfunctions following spinal cord injury (Q37682800) (← links)
- Oral cavity and oropharyngeal squamous cell carcinoma genomics (Q38126153) (← links)
- The mutational spectrum of squamous-cell carcinoma of the head and neck: targetable genetic events and clinical impact (Q38203467) (← links)
- Sequence-dependent effects of ZD1839 ('Iressa') in combination with cytotoxic treatment in human head and neck cancer (Q38282688) (← links)
- Influence of epidermal growth factor receptor (EGFR), p53 and intrinsic MAP kinase pathway status of tumour cells on the antiproliferative effect of ZD1839 ("Iressa") (Q38283276) (← links)
- Use of combined molecular biomarkers for prediction of clinical outcomes in locally advanced tonsillar cancers treated with chemoradiotherapy alone (Q38425141) (← links)
- Biomarkers predicting chemotherapy response in head and neck squamous cell carcinoma: a review (Q38597457) (← links)
- Reactive oxygen species and p21Waf1/Cip1 are both essential for p53-mediated senescence of head and neck cancer cells (Q38900561) (← links)
- Gambogic acid‐induced degradation of mutant p53 is mediated by proteasome and related to CHIP (Q39602480) (← links)
- Delineation and candidate gene mutation screening of the 18q22 minimal region of deletion in head and neck squamous cell carcinoma. (Q40718188) (← links)
- Evaluation of p53, caspase-3, Bcl-2, and Ki-67 markers in oral squamous cell carcinoma and premalignant epithelium in a sample from Alava Province (Spain). (Q41979720) (← links)
- Genetic and epigenetic characterization of the tumors in a patient with a tongue primary tumor, a recurrence and a pharyngoesophageal second primary tumor (Q42026346) (← links)
- Glutathione-associated enzymes in head and neck squamous cell carcinoma and response to cisplatin-based neoadjuvant chemotherapy. (Q43690877) (← links)
- p53 polymorphism influences response in cancer chemotherapy via modulation of p73-dependent apoptosis (Q44426545) (← links)
- Generation of Monoclonal Antibodies to the AML1-ETO Fusion Protein: Strategies for Overcoming High Homology (Q44513708) (← links)
- Comprehensive assessment of prognostic markers for sinonasal squamous cell carcinoma (Q46609517) (← links)